Germany’s Fresenius in Talks to Buy U.S. Drug Maker Akorn

German health-care company Fresenius is in discussions to acquire U.S. firm Akorn, a maker of generic drugs that is currently valued at about $3.7 billion.

Popular Posts


EOF

(Visited 1 times, 1 visits today)

Vote on this story -->>>


this is a single

THE MIAMI METROPOLIS -your source for news, music, sports, movies, restaurants, reviews, weather, travel, arts, tech and events in Miami